Federal judge approves Purdue Pharma's bankruptcy plan requiring Sackler family to pay $7 billion and surrender company ownership. Thousands of opioid victims to receive compensation in historic settlement.
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Sri Aurobindo Public School Baddi successfully organized an inter-school quiz competition featuring 12 schools. The event promoted academic excellence and healthy competition among students.
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
India's DCGI orders nationwide inspections of small pharma units as WHO flags toxic cough syrups. MSMEs struggle to meet new Schedule M compliance deadline of January 2026.
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Discover how Waaree Renewables Technologies became a multibagger sensation, delivering staggering returns while defying broader market trends. Learn why this renewable energy stock continues to attract investor attention.
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Discover why this undervalued small-cap IT stock is creating massive buzz with 30% gains in just three trading sessions. Expert analysis reveals whether this rally has legs or if it's just market hype.
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
Discover how Krishival Foods became a stock market sensation with explosive 400% returns. This FMCG multibagger is inching closer to its 52-week high, creating massive wealth for investors. Learn why analysts are bullish on this rising star.
Discover how CoLab Platforms became India's latest stock market phenomenon with unprecedented 19,500% returns over five years and 96 consecutive upper circuits, creating massive wealth for investors.
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Discover how Waaree Renewables Technologies delivered staggering 1,100% returns in just 12 months, hitting upper circuits repeatedly. Learn what's driving this solar energy stock's phenomenal performance.
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
Discover how a small-cap multibagger stock delivered staggering 1350% returns year-to-date as it prepares to declare Q2 FY2025 results and interim dividend. Board meeting date revealed!
Discover three high-potential stocks trading below ₹200 that could deliver strong returns. Expert analysis from Mehul Kothari of Anand Rathi reveals hidden gems in today's volatile market.
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Discover how this small-cap multibagger stock delivered explosive Q2 FY2025 results with 94% profit surge and 39% revenue growth, triggering massive investor interest.
Discover how a little-known small-cap stock under ₹50 delivered staggering 600% returns in just five years and why analysts are watching it closely now.
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.